Phase I/II Study of Oral S-1 Plus f Oxaliplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric Cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Jun 2016 Planned End Date changed from 1 May 2017 to 1 Apr 2017.
- 12 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2012 New trial record